AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus
Patients suffering from congenital nephrogenic diabetes insipidus (NDI) fail to concentrate urine due to mutations in vasopressin type 2 receptor (V2R). Here Ando et al. show that agents disrupting the interaction between PKA and AKAPs restore aquaporin-2 activity downstream of V2R, offering a thera...
Guardado en:
Autores principales: | Fumiaki Ando, Shuichi Mori, Naofumi Yui, Tetsuji Morimoto, Naohiro Nomura, Eisei Sohara, Tatemitsu Rai, Sei Sasaki, Yoshiaki Kondo, Hiroyuki Kagechika, Shinichi Uchida |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c60b14a92e94b27bd57f69fed3d984d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway
por: Fumiaki Ando, et al.
Publicado: (2016) -
Functional characterization of a loss-of-function mutant I324M of arginine vasopressin receptor 2 in X-linked nephrogenic diabetes insipidus
por: Lixia Wang, et al.
Publicado: (2021) -
Mechanism of neuroprotective mitochondrial remodeling by PKA/AKAP1.
por: Ronald A Merrill, et al.
Publicado: (2011) -
Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus
por: Takafumi Suzuki, et al.
Publicado: (2017) -
Atorvastatin does not ameliorate nephrogenic diabetes insipidus induced by lithium or potassium depletion in mice
por: Maria L. Thomsen, et al.
Publicado: (2021)